Categories for Uncategorised

Sustainable Logistics

Published by

May 12, 2015 11:33 am | Leave your thoughts



Logistics is the management of moving products from point A to point B, including prompt planning and organisation to carry out process effectively. At Client-Pharma, manage warehousing, inventory and order fulfilment to ensure our clients get the quality service we’ve promised. During logistics management, consideration must be taken regarding the environment and operation costs. The logistics industry


Supporting the Local Community

Published by

May 12, 2015 11:23 am | Leave your thoughts


Clinical trial supply services and solutions

Since Client-Pharma launched in 2013, we’ve been working in the heart of local communities to help improve people’s lives whether it’s through funding, training, sponsorship or fundraising. As big supporters of rugby, Client-Pharma jumped at the chance to sponsor our local rugby club, Barton under Needwood. Formed in 1990 with just one adult team playing


Client-Pharma returns to the Arab Health Exhibition

Published by

May 12, 2015 11:22 am | Leave your thoughts


pharma distribution solutions

As you may know, last year we attended the Arab Health exhibition in Dubai which aimed to showcase the latest products, services and achievements in the pharmaceutical world. Amongst the vast array of health professionals and varied services, Client-Pharma will be there networking and seeing just how far the industry has developed over the past


Risk mitigation and competitiveness

Published by

May 12, 2015 11:21 am | Leave your thoughts



UPS published its seventh Pain in the Chain survey last month, which revealed a correlation between a risk-informed approach and the rewards of global success. The survey polled 530 senior-level supply chain decision makers in the healthcare industry from the United States, Canada, Western Europe, Asia, and Latin America. Regulatory compliance, for the third consecutive


Global biosimilars market

Published by

May 12, 2015 11:21 am | Leave your thoughts


Clinical trial supply services and solutions

New research from the RAND Corporation research institute published this month, believes the introduction of biosimilar versions of complex biologic drugs to treat illnesses such as cancer and rheumatoid arthritis could cut US spending on biologics by $44 billion over the next decade. The global market for biosimilars is predicted to expand 20-fold in the


1 4 5 6